Teneglee-M 500 Tablets

Teneglee M 500 Tablets contain teneligliptin which is a dipeptidyl peptidase-4 (DPP-4) inhibitor and Metformin, a biguanide with antihyperglycaemic effects, lowering both basal and postprandial plasma glucose.

Dosage Form

Tablet

Route of Administration

Oral

Composition

Each uncoated bilayered tablet contains:

Teneligliptin Hydrobromide Hydrate Eq. to Teneligliptin I.P. 20 mg
Metformin Hydrochloride (in sustained release form) I.P. 500 mg
Excipients q.s.

Indications

Teneglee M 500 Tablets are indicated for the treatment of Type 2 Diabetes Mellitus as an adjunct to diet and exercise.

Precautions

Use with caution in patients with renal impairment, hepatic impairment, heart failure, or conditions that may increase the risk of lactic acidosis. Regular monitoring of blood glucose and kidney function is recommended. Patients should avoid excessive alcohol consumption while taking this medication. Use during pregnancy and lactation only under medical supervision.

Presentation

10 × 10 Tablets

Storage

Store protected from light and moisture at a temperature not exceeding 30°C.

GLOBAL HORIZONS

Your Efforts Extended Through a Partnership That's Better Together

Become a Dealer